Prescription Drugs - Austria

  • Austria
  • The Prescription Drugs market in Austria is expected to experience significant growth in the coming years.
  • According to projections, the market's revenue is set to reach US$4.69bn by 2024.
  • This growth is expected to continue at an annual rate of 3.35% from 2024 to 2029, resulting in a market volume of US$5.53bn by 2029.
  • When compared to other countries globally, United States is projected to generate the highest revenue in the Prescription Drugs market, reaching a staggering US$358.90bn in 2024.
  • This demonstrates the dominance of the US market in this sector.
  • In terms of per person revenues, individuals in Austria are projected to generate US$0.52k in 2024.
  • This figure showcases the financial impact of the Prescription Drugs market on the population of Austria.
  • Austria's prescription drug market is experiencing a surge in demand for innovative and personalized medications.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Austria has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Austria have played a crucial role in driving the growth of the Prescription Drugs (Pharmacies) market. Customers in Austria have shown a strong preference for convenience and accessibility when it comes to purchasing prescription drugs. As a result, there has been an increase in the number of pharmacies and online platforms that offer prescription drugs, making it easier for customers to access the medications they need. Trends in the market have also contributed to the growth of the Prescription Drugs (Pharmacies) market in Austria. One significant trend is the increasing demand for generic drugs. Generic drugs offer the same therapeutic benefits as brand-name drugs but at a lower cost. This has led to increased affordability and accessibility of prescription drugs for customers in Austria, driving the growth of the market. Another trend in the market is the rising importance of e-commerce in the sale of prescription drugs. Online platforms have made it more convenient for customers to purchase their medications, especially for those living in remote areas or with limited mobility. The ease of ordering prescription drugs online has contributed to the growth of the market in Austria. Local special circumstances in Austria have also played a role in the development of the Prescription Drugs (Pharmacies) market. Austria has a well-developed healthcare system with a strong emphasis on patient care and safety. This has led to strict regulations and quality standards for pharmacies and the sale of prescription drugs. The high level of regulation ensures that customers have access to safe and effective medications, which has further boosted customer confidence in the market. Underlying macroeconomic factors have also contributed to the growth of the Prescription Drugs (Pharmacies) market in Austria. The country's stable economy and high disposable income levels have allowed customers to afford prescription drugs and contribute to the growth of the market. Additionally, the aging population in Austria has increased the demand for prescription drugs, as older individuals require more medications to manage their health conditions. In conclusion, the Prescription Drugs (Pharmacies) market in Austria has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The emphasis on convenience and accessibility, the increasing demand for generic drugs, the rise of e-commerce, and the strict regulations in Austria have all contributed to the development of the market. Additionally, the stable economy and aging population have further fueled the growth of the Prescription Drugs (Pharmacies) market in Austria.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)